LAMIVUDINE - 60505-3252-0 - (lamivudine)

Alphabetical Index


Drug Information of LAMIVUDINE

Product NDC: 60505-3252
Proprietary Name: LAMIVUDINE
Non Proprietary Name: lamivudine
Active Ingredient(s): 300    mg/1 & nbsp;   lamivudine
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of LAMIVUDINE

Product NDC: 60505-3252
Labeler Name: Apotex Corp.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA091606
Marketing Category: ANDA
Start Marketing Date: 20111202

Package Information of LAMIVUDINE

Package NDC: 60505-3252-0
Package Description: 10 BLISTER PACK in 1 CARTON (60505-3252-0) > 10 TABLET, FILM COATED in 1 BLISTER PACK

NDC Information of LAMIVUDINE

NDC Code 60505-3252-0
Proprietary Name LAMIVUDINE
Package Description 10 BLISTER PACK in 1 CARTON (60505-3252-0) > 10 TABLET, FILM COATED in 1 BLISTER PACK
Product NDC 60505-3252
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name lamivudine
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20111202
Marketing Category Name ANDA
Labeler Name Apotex Corp.
Substance Name LAMIVUDINE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA]

Complete Information of LAMIVUDINE


General Information